Sign in
Taking peopleNo phase

Royal Jelly Supplementation in Unexplained Male Infertility

Key facts

Who runs it
Medipol University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
1 Feb 2026
Expected to end
1 Dec 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Lyophilized Royal Jelly
  • Placebo
Record updated
19 August 2026

Who can take part

Age
18 years to 45 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Men aged 18-45 years. History of infertility for at least 1 year despite unprotected intercourse; Diagnosis of unexplained infertility with Normozoospermia according to WHO 2021 (6th Ed.) criteria:; Concentration ≥ 16 million/mL Total Motility ≥ 42% Progressive Motility ≥ 30% Normal Morphology (Kruger) ≥ 4% Female partner with normal gynecological evaluation (regular ovulation, normal ovarian reserve, and proven tubal patency via HSG); Normal serum hormone levels (Testosterone, FSH, LH)

Who cannot take part

  • Any abnormality in spermiogram (Oligo-, Asteno-, or Teratozoospermia). Presence of clinical varicocele. Leukocytospermia (>1 million/mL) or active infection. History of smoking (>5 cigarettes/day) or BMI > 30 kg/m². Use of any antioxidant supplementation within the last 3 months

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized, double-blind, placebo-controlled clinical trial investigates the effects of oral Royal Jelly supplementation on sperm DNA fragmentation and pregnancy rates in couples with unexplained infertility. While routine semen analysis appears normal (normozoospermia) in these patients, underlying Sperm DNA Fragmentation (SDF) and oxidative stress are believed to contribute to reproductive failure.

Read full original descriptionShow less

Participants will be randomized to receive either 750 mg of lyophilized Royal Jelly or a placebo daily for a period of 3 months (90 days). The study aims to evaluate whether the antioxidant properties of Royal Jelly can improve sperm chromatin integrity, reduce oxidative stress markers, and increase spontaneous pregnancy rates compared to the control group

The 2 groups in the trial

  • Royal JellyTreatment being tested

    Participants will receive 750 mg of Lyophilized Royal Jelly capsules daily for 3 months (90 days).

    Treatment: Lyophilized Royal Jelly

  • Placebo GroupPlacebo, for comparison

    Participants will receive inert capsules identical in appearance and taste to the experimental drug daily for 3 months (90 days).

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Oral Royal Jelly Supplementation on Sperm DNA Fragmentation Index and Pregnancy in Couples With Unexplained Infertility: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study
Criteria questions
Built from NCT07337265, who can take part
Record updated
19 August 2026